Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach

Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated w...

Full description

Bibliographic Details
Main Authors: Cătălina Roxana Ferea, Stejara Nicoleta Mihai, Gabriela Balan, Minerva Codruta Badescu, Dana Tutunaru, Alin Laurențiu Tatu
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/3/809
_version_ 1797610620680404992
author Cătălina Roxana Ferea
Stejara Nicoleta Mihai
Gabriela Balan
Minerva Codruta Badescu
Dana Tutunaru
Alin Laurențiu Tatu
author_facet Cătălina Roxana Ferea
Stejara Nicoleta Mihai
Gabriela Balan
Minerva Codruta Badescu
Dana Tutunaru
Alin Laurențiu Tatu
author_sort Cătălina Roxana Ferea
collection DOAJ
description Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones, muscles, eyes, ears, mouth, heart, lung, liver, kidneys, intestines, and spleen may be affected by SS as extracutaneous manifestations. More and more cases have been found to be associated with malignancies, particularly myelodysplastic syndrome, and, less frequently, other hematologic malignancies or solid tumors. Approximately 21% of patients with SS have an associated malignancy and up to 80% of MASS cases are associated with hematological diseases, predominantly myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Myelodysplastic syndrome is a clonal disease of the bone marrow characterized by inefficient hematopoiesis, dysplasia of the bone marrow and peripheral cytopenias. Affected patients have a high risk of leukemic transformation. After analyzing later studies and current practical aspects regarding MDS-related SS, we suggest an algorithm for evaluating these patients.
first_indexed 2024-03-11T06:17:47Z
format Article
id doaj.art-f251d6591fe2442185db196e5ad31bcb
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T06:17:47Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-f251d6591fe2442185db196e5ad31bcb2023-11-17T12:12:40ZengMDPI AGLife2075-17292023-03-0113380910.3390/life13030809Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary ApproachCătălina Roxana Ferea0Stejara Nicoleta Mihai1Gabriela Balan2Minerva Codruta Badescu3Dana Tutunaru4Alin Laurențiu Tatu5Faculty of Medicine, “Carol Davila” University of Medicine and Farmacy, 020021 Bucharest, RomaniaFaculty of Medicine, “Carol Davila” University of Medicine and Farmacy, 020021 Bucharest, RomaniaFaculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, RomaniaDepartment of Internal Medicine, “Grigore T. Popa” University of Medicine and Farmacy, 700115 Iași, RomaniaFaculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, RomaniaFaculty of Medicine and Pharmacy, ”Dunărea de Jos” University of Galați, 800008 Galați, RomaniaSweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones, muscles, eyes, ears, mouth, heart, lung, liver, kidneys, intestines, and spleen may be affected by SS as extracutaneous manifestations. More and more cases have been found to be associated with malignancies, particularly myelodysplastic syndrome, and, less frequently, other hematologic malignancies or solid tumors. Approximately 21% of patients with SS have an associated malignancy and up to 80% of MASS cases are associated with hematological diseases, predominantly myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Myelodysplastic syndrome is a clonal disease of the bone marrow characterized by inefficient hematopoiesis, dysplasia of the bone marrow and peripheral cytopenias. Affected patients have a high risk of leukemic transformation. After analyzing later studies and current practical aspects regarding MDS-related SS, we suggest an algorithm for evaluating these patients.https://www.mdpi.com/2075-1729/13/3/809sweet syndromemyelodysplastic syndromemalignancy-associated SSmanagementneutrophilic dermatosis
spellingShingle Cătălina Roxana Ferea
Stejara Nicoleta Mihai
Gabriela Balan
Minerva Codruta Badescu
Dana Tutunaru
Alin Laurențiu Tatu
Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
Life
sweet syndrome
myelodysplastic syndrome
malignancy-associated SS
management
neutrophilic dermatosis
title Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
title_full Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
title_fullStr Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
title_full_unstemmed Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
title_short Sweet Syndrome Associated with Myelodysplastic Syndrome—A Review of a Multidisciplinary Approach
title_sort sweet syndrome associated with myelodysplastic syndrome a review of a multidisciplinary approach
topic sweet syndrome
myelodysplastic syndrome
malignancy-associated SS
management
neutrophilic dermatosis
url https://www.mdpi.com/2075-1729/13/3/809
work_keys_str_mv AT catalinaroxanaferea sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach
AT stejaranicoletamihai sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach
AT gabrielabalan sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach
AT minervacodrutabadescu sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach
AT danatutunaru sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach
AT alinlaurentiutatu sweetsyndromeassociatedwithmyelodysplasticsyndromeareviewofamultidisciplinaryapproach